Evaluation of GWAS-Identified Genetic Variants for Gastric Cancer Survival

This preliminary study suggests that a GWAS-identified genetic variant in PLCE1 may serve as a potential biomarker for GC survival. Additional replication with larger samples size is warranted to further investigation.